awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55429844-2D2CDD20-7EB9-4E06-9A09-3CEFD0022A51
Q55429844-2D2CDD20-7EB9-4E06-9A09-3CEFD0022A51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-2D2CDD20-7EB9-4E06-9A09-3CEFD0022A51
Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
P2860
Q55429844-2D2CDD20-7EB9-4E06-9A09-3CEFD0022A51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-2D2CDD20-7EB9-4E06-9A09-3CEFD0022A51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b45e94a813a20fde73a8fd8006532127b40e6e6
P2860
Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.